Zoetis, Inc. Class A

ZTS

$162.47

+33.32% (1 year change)

Avg closing price

Price range

Market Cap

$77.7 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$1.55 Billion

Total revenue in the last quarter.

Net Income

$377 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$3.39

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.764 (0.47%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

48.16x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$553 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

10,600

The number of full time employees.

Revenue & Earnings

Balance Sheet

Zoetis, Inc. Class A

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

News

Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference

Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to participate in the Credit Suisse Virtual Healthcare Conference on Nov. 10.

Business Wire Business Wire, 2 days ago
Livestock Animal Vaccine Market Research and Share by Forecast 2020-2025 | Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly

Livestock Animal Vaccine Market Research and Share by Forecast 2020-2025 | Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly

This report provides in-depth study on the current state of the Global Livestock Animal Vaccine Market 2020-2025. Key players in the Global Livestock Animal Vaccine Market have been identified thro...

OpenPR OpenPR, 5 days ago
Look who's dropped in to Zoe's Place with an extra special donation

Look who's dropped in to Zoe's Place with an extra special donation

Teesside comic Roy Chubby Brown's money will help provide care for poorly babies

Teesside Live Teesside Live, 7 days ago